The tumor-specific expression of NIS genes has been identified in many types of tumors, including prostate, colon, and liver cancer, suggesting that NIS expression under the control of tissue-specific promoters could be helpful in diagnostic and therapeutic applications [27,28,29,30]. Here, SLC5A5 is linked to neoplasm.